Activation of Rac1 GTPase signaling is stimulated by phosphorylation and release of RhoGDI by the effector p21-activated kinase 1 (PAK1), but it is unclear what initiates this potential feed-forward mechanism for regulation of Rac activity. Phosphatidic acid (PA), which is produced from the lipid second messenger diacylglycerol (DAG) by the action of DAG kinases (DGKs), is known to activate PAK1. Here, we investigated whether PA produced by DGK initiates RhoGDI release and Rac1 activation. In DGK-deficient fibroblasts PAK1 phosphorylation and Rac1-RhoGDI dissociation were attenuated, leading to reduced Rac1 activation after platelet-derived growth factor stimulation. The cells were defective in Rac1-regulated behaviors, including lamellipodia formation, membrane ruffling, migration, and spreading. Wild-type DGK, but not a kinase-dead mutant, or addition of exogenous PA rescued Rac activation. DGK stably associated with PAK1 and RhoGDI, suggesting these proteins form a complex that functions as a Rac1-selective RhoGDI dissociation factor. These results define a pathway that links diacylglycerol, DGK, and PA to the activation of Rac1: the PA generated by DGK activates PAK1, which dissociates RhoGDI from Rac1 leading to changes in actin dynamics that facilitate the changes necessary for cell motility.
INTRODUCTION
Rho GTPases regulate gene transcription, cell cycle progression, vesicular traffic, and cell polarity (Jaffe and Hall, 2005; Ridley, 2006) but are best known for their ability to coordinate alterations in cellular actin networks that regulate cell morphology. Such changes are necessary for directed cell migration during embryogenesis, inflammation, wound healing, and tumor metastasis (Burridge and Wennerberg, 2004) . In mammalian cells, Rac1 promotes actin polymerization and focal complex assembly, leading to lamellipodia protrusion and membrane ruffle formation; Cdc42 regulates filopodial extension; and Rho promotes the assembly of actin stress fibers and focal adhesions (Ridley et al., 1992; Nobes and Hall, 1995) .
All Rho GTPases cycle between inactive GDP-bound and active GTP-bound conformations; the active versions interact with specific downstream effectors to elicit distinct biological responses. This cycle is tightly regulated by guanine nucleotide exchange factors (GEFs), which activate GTPases by promoting the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP), and by GTPaseactivating proteins (GAPs), which inactivate Rho proteins by enhancing their intrinsic GTPase activity. A third class of proteins, guanine nucleotide dissociation inhibitors (GDIs), regulates Rho GTPase function in as many as three distinct ways. RhoGDI, the best characterized member, 1) prevents GDP dissociation, 2) inhibits intrinsic or GAP-stimulated GTP hydrolysis (Chuang et al., 1993b) , and 3) regulates GTPase partitioning between the cytosol and plasma membrane (Olofsson, 1999) . The latter task is accomplished by sequestering the GTPases as soluble cytosolic complexes in which the C-terminal membrane-targeting lipid moiety is prevented from interacting with membranes (Dermardirossian and Bokoch, 2005; Dovas and Couchman, 2005) . Dissociation of GTPases from RhoGDI is a prerequisite for membrane association and activation by GEFs. Because the majority of Rho GTPase protein exists in a biologically inactive cytosolic complex with RhoGDI in resting cells, this a major point of regulation of Rho GTPase activity and function (Chuang et al., 1993a; Olofsson, 1999) .
The selective activation of individual Rho GTPases by growth and/or adhesive factors implies that separate mech-anisms must exist to dissociate them from cytosolic RhoGDI complexes and target them to the appropriate membrane domain. The means by which Rho family proteins are released from RhoGDI is poorly understood, and so far no common mechanistic theme has emerged. Dissociation seems to use several different mechanisms, including direct phosphorylation by protein kinases (Bourmeyster et al., 1992; Mehta et al., 2001; Dermardirossian et al., 2004) and protein displacement factors such as integrins, ERM proteins, and the p75 NGF receptor (Takahashi et al., 1997; Del Pozo et al., 2002; Yamashita and Tohyama, 2003) .
Accumulating evidence suggests negatively charged phospholipids play an important role in RhoGDI release (Bourmeyster et al., 1992; Chuang et al., 1993a; Faure et al., 1999; Dovas and Couchman, 2005; Ugolev et al., 2006) . Among those shown to dissociate RhoGDI, phosphatidic acid (PA) is particularly interesting because it also activates p21-activated kinase 1 (PAK1) , a downstream effector of activated Rac and Cdc42 implicated in the regulation of multiple cellular activities, including cytoskeletal dynamics (Bokoch, 2003) . Recently, PAK1 was shown to bind to and phosphorylate RhoGDI, resulting in the selective release of Rac1 (Dermardirossian et al., 2004) . Thus, PA-mediated activation of PAK1 might initiate Rac signaling, but precisely how this occurs and the source of PA are unclear.
Diacylglycerol kinases (DGKs) phosphorylate the lipid second messenger diacylglycerol (DAG) to yield PA and are thus a potential source for PA-mediated Rac activation. Supporting this possibility, Tolias et al. (1998) found that Rac/ RhoGDI exists in a complex with a DGK, and we recently demonstrated that the ubiquitously expressed isoform binds directly to Rac1 (Yakubchyk et al., 2005) . Here, we investigated the possibility that DGK might be part of a Rac/PAK1 complex and a source of PA for PAK1 activation by analyzing the phenotype and biochemical properties of embryonic fibroblasts from DGK-null mice. Our findings demonstrate that DGK is part of a signaling complex that functions as a Rac1-selective RhoGDI dissociation factor and define a direct link between lipid second messengers and regulation of the actin cytoskeleton.
MATERIALS AND METHODS

Antibodies
Monoclonal hemagglutinin (HA), actin, tubulin, and ␣-actinin antibodies were from Sigma-Aldrich (St. Louis, MO). Monoclonal Rac1 and paxillin antibodies were from BD Biosciences (San Jose, CA). Monoclonal RhoA and polyclonal RhoGDI were from Santa Cruz Biotechnology (Santa Cruz, CA). Polyclonal PAK1 was from Cell Signaling Technology (Danvers, MA). AntipPAK1 was a gift from Dr. Jonathan Chernoff (Fox Chase Cancer Center, Philadelphia, PA). The DGK antibody was a gift from Dr. Kaoru Goto (Yamagata University School of Medicine, Yamagata, Japan). Polyclonal Phospho-Akt Ser473 and Akt were from Cell Signaling Technology. Monoclonal phospho-tyrosine (clone 4G10) was from Millipore Bioscience Research Reagents (Temecula, CA). A polyclonal antibody raised against the N terminus of DGK is as described previously (Topham et al., 1998) . Monoclonal antibody 1351 was a gift from Dr. Stanley Froehner (University of Washington, Seattle, WA). AlexaFluor 488-and 594-conjugated secondary antibodies and phalloidin were from Invitrogen (Carlsbad, CA). Horseradish peroxidase-conjugated anti-rabbit and anti-mouse secondary antibodies were from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA).
Reagents
Matrigel was from BD Biosciences. FuGENE 6 transfection reagent was from Roche Diagnostics (Indianapolis, IN). DMEM was from Invitrogen. Protein A agarose was from Millipore Bioscience Research Reagents. 1,2-dioctanoyl-snglycero-3-phosphate (08:0 PA), 1,2-dioctanoyl-sn-glycerol (08:0 DAG), and 1-hexanoyl-2-hydroxy-sn-glycero-3-phosphate (06:0 LPA) were from Avanti Polar Lipids (Alabaster, AL). All other reagents were from Sigma-Aldrich.
Plasmids and Constructs
Plasmids encoding wild-type DGK and a kinase-dead mutant (DGK ⌬ATP ), both with three tandem, N-terminal HA epitope tags, as well as DGK with a C-terminal FLAG epitope tag (DGK FLAG ), have been described previously (Topham et al., 1998; Hogan et al., 2001) . The PAK1-p21-binding domain (PBD) and Rhotekin-RBD constructs were as described previously (Sander et al., 1998; Ren et al., 1999) . N-terminal myc-tagged Rac1 V12 in pEFmPLINK was a gift from Dr. Andrew Thorburn (University of Colorado, Denver, CO). N-terminal yellow fluorescent protein (YFP)-tagged Rac1 V12 was generated by subcloning Rac1 V12 from pEFmPLINK into the Kpnl and Apal sites of pEYFP-C1 (Clontech, Mountain View, CA). The full-length GST-RhoGDI construct was generated by subcloning mouse RhoGDI from pcDNA 3.1 (UMR cDNA Resource Center; www.cdna.org) into the EcoRI and XhoI cloning sites of pGEX-4T-1.
Cell Culture and Transfection/Infection
Primary mouse embryonic fibroblasts (MEFs) were isolated from wild-type (ϩ/ϩ) and DGK-deficient (Ϫ/Ϫ) embryos (13.5 d after coitus) as described previously (Robertson, 1987) . MEFs were cultured in DMEM supplemented with 10% fetal calf serum (FCS), 2 mM l-glutamine, 100 U ml Ϫ1 penicillin, and 100 U ml Ϫ1 streptomycin and grown at 37°C, 5% CO 2 . Immortalized cell lines were generated by transfecting MEFs with pcDNA3.1 harboring a simian virus 40 large T antigen expression cassette and the Sh ble antibiotic resistance gene. Stable clones were selected in media containing 200 g ml Ϫ1 Zeocin (Invitrogen). For Rac1 V12 experiments, cells were transfected with either myc-or YFPtagged Rac1 V12 constructs for 24 h. Cells were fixed in 4% paraformaldehyde (PFA) and then processed for immunocytochemistry (for myc-Rac1 V12 ) or live microscopy (for YFP-Rac1
V12
). Cloning and production of adenoviral constructs encoding green fluorescent protein (GFP), wild-type (wt) DGK, DGK FLAG , or the kinase-dead mutant have been described previously (Yakubchyk et al., 2005) . For rescue experiments, fibroblasts were infected with adenoviruses at a multiplicity of infection of 100 -250 (for ruffling rescue and Rac1 activity assays) or 1000 (for wounding assays) for 1 h at 37°C. Cells were further incubated for 24 -36 h under standard growth conditions.
Immunofluorescence Microscopy and Quantification of Actin-based Structures
Fibroblasts were seeded onto Matrigel-coated coverslips, serum starved overnight, and then stimulated with either platelet-derived growth factor (PDGF)-BB (Sigma-Aldrich) or vehicle (0.14M HCl and 0.1% bovine serum albumin [BSA] ). Cells were fixed and processed as described previously (Abramovici and Gee, 2007) . Images were obtained using a charge-coupled device (CCD) camera on an Axioskop 2 microscope (Carl Zeiss, Jena, Germany). To quantify actin-based structures, fixed cells were labeled with AlexaFluor 488-or 594-conjugated phalloidin. A lamellipodium was an area of the cell with thick peripheral F-actin within a broad, sheet-like region; a peripheral ruffle was a curvilinear accumulation of F-actin at the cell edge; circular ruffles were circular accumulations of F-actin on the dorsal cell surface, and filopodia finger-like, actin-rich protrusions. A minimum of 200 cells were counted for each phenotype. For rescue experiments, all cells were assumed to have been infected. Cell and ruffle surface areas were measured using the "outline" tool function in AxioVision 4.5 software (Carl Zeiss).
Adhesion Assays
Adhesion assays were performed as described previously (Wagner et al., 2002) . Cells were plated at a density of 2 ϫ 10 4 /coverslip for the indicated times and processed for immunofluorescence microscopy as described above.
Wounding Assays
Cell monolayers on 12-mm coverslips were scraped with a 20-gauge needle, generating wounds ϳ0.2 ϫ 12 mm. Three wounds were made on each coverslip. Cells were fixed with 0.5% PFA immediately (0 h) or after 2 h incubation at 37°C. Cells were stained with AlexaFluor-conjugated phalloidin (or indicated antibodies) and prepared for immunofluorescence microscopy. Photomicrographs were taken at 500-m intervals along the length of the wound, images were exported into AxioVision 4.5 software, and the extent of cell migration was quantified by two independent methods, both yielding similar results. The wound width was determined by lines drawn perpendicular to the wound edge at 50-m intervals. The percentage wound closure was calculated by subtracting wound width at 2 h from 0 h and dividing the resulting number by wound width at 0 h. In the second method, the area devoid of cells was manually traced with the outline tool function and the wound area automatically calculated by the software. Measurements at 2 h were then subtracted from the wound area at 0 h and divided by wound area at 0 h. Data were exported into Excel (Microsoft, Redmond, WA), and then graphed using SigmaPlot software (SPSS, Chicago, IL).
Transwell Migration Assays
Modified Boyden chamber assays were performed as described previously (Sander et al., 1998) . Fibronectin (FN)-coated filters were placed into the lower chamber containing either 0.1% BSA or 50 ng ml Ϫ1 PDGF-BB. Wild-type or DGK-null MEFs (1 ϫ 10 5 ) resuspended in 0.1% BSA in DMEM were added to the upper chamber and allowed to migrate for up to 12 h. Cells were fixed with 4% PFA for 30 min and stained with 4,6-diamidino-2-phenylindole. Ten randomly selected fields were photographed and counted for each experiment.
Immunoprecipitation and Glutathione Transferase (GST) Pull-Down Experiments
Immunoprecipitations were carried out essentially as described previously (Hogan et al., 2001) . To measure Rac1-RhoGDI dissociation, wt and DGK-null MEFs were serum-starved overnight and then stimulated with 50 ng ml Ϫ1 PDGF for 5 min. Cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.5, 50 mM NaCl, 5 mM MgCl 2 , 1% NP-40, 5% glycerol, 1 mM dithiothreitol (DTT), and protease inhibitors and centrifuged at 18,000 ϫ g for 10 min at 4°C. Equivalent amounts of protein (ϳ1 mg) were incubated with 5 g RhoGDI antibody or control rabbit immunoglobulin G (IgG) for 4 h at 4°C. Then, 40 l of 50% protein G agarose slurry was added for 1.5 h. The beads were washed with lysis buffer, resuspended in 1ϫ reducing sample buffer, and analyzed for bound RhoGDI or Rac1 by immunoblotting. GST pull-down experiments were carried out as described previously (Yakubchyk et al., 2005) by using lysis buffer without MgCl 2 . For some experiments, wt fibroblasts were infected with HA-DGK, and the cells were harvested 24 h later.
Rho GTPase Activity Assays
Levels of active Rac1 and Cdc42 were measured using a GST-PAK1 PBD pull-down assay (Sander et al., 1998) . Cells were serum starved overnight and then stimulated with 50 ng ml Ϫ1 PDGF for 3 min for Rac1 assays or with 100 ng ml Ϫ1 bradykinin for 4 min for Cdc42 assays. For lipid assays, serumstarved cells were treated with 100 nM PA, DAG, LPA, or vehicle for 25 min at 37°C. After stimulation, media were removed, and cells were immediately harvested in chilled lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 20 mM MgCl 2 , and protease inhibitors). Lysates were incubated for 10 min at 4°C and then centrifuged at 18,000 ϫ g for 10 min. Equivalent amounts of protein were incubated with GST-PAK1 PBD beads for 30 min at 4°C. The beads were washed with lysis buffer, boiled in reducing sample buffer, and eluted proteins assayed for bound Rac1 or Cdc42 by immunoblotting. For PAK1 inhibition experiments, cells were incubated with dimethyl sulfoxide or 30 M of the PAK1 inhibitor IPA-3 (Deacon et al., 2008) for 20 min at 37°C before stimulation with 25 ng/l Ϫ1 PDGF for 5 min.
Quantification of Phosphorylated PAK1
Fibroblasts were seeded onto 100-mm dishes and grown until confluent. Cells were treated as indicated and then lysed directly in reducing sample buffer. Lysates were boiled, sonicated, and analyzed by immunoblotting using an affinity-purified phospho-specific PAK1 antibody (Sells et al., 2000) or a polyclonal anti-PAK1 antibody. Digital images were captured using a Kodak Image Station 440 CF (Eastman Kodak, Rochester, NY), and band intensity was measured by densitometric analysis. To calculate relative amounts of pPAK1, the intensity of the upper band of the pPAK doublet was normalized to total PAK and expressed as a percentage of the unstimulated, wt condition.
Live-Cell Imaging
Imaging was carried out using an Axiovert 200 M microscope (Carl Zeiss) with a stage-fixed cell chamber at 37°C, 5% CO 2 . Equal numbers of wild-type or DGK-null fibroblasts were cultured in 35-mm dishes (MatTek, Ashland, MA) and were serum-starved overnight and then stimulated with 50 ng ml Ϫ1 PDGF for 15 min. For ruffling experiments, cells were imaged at a 100ϫ magnification by using a differential interference contrast III filter, and filmed at 10-s intervals for 15 min by using an Axiocam HRm charge-coupled device (CCD) camera.
Small Interfering RNA (siRNA) Experiments
Two siRNA oligonucleotides (oligo) corresponding to nucleotides 1679-1701 and 2480-2502 of human DGK and control scrambled versions were used: oligo 1 sense, ACA GCC GCU UUC GGA AUA AdTdT and antisense, UUA UUC CGA AAG CGG CUG UdTdT; oligo 2 sense, UCG CAC AGG AUG GA UUU AdTdT and antisense, UAA AUC UCA UCC UGU GCG AdTdT; scrambled oligo 1 sense, GGU CAU UCC AAC GAC AGU AdTdT and ant-sense, UAC UGU CGU UGG AAU GACCdTdT; and scrambled oligo 2 (sense), GGA AAG UAU CGC GUU CUA AdTdT and antisense, UUA GAAC GCG AUA CUU UCC dTdT.
HeLa cells were grown to ϳ80% confluence in growth medium (DMEM supplemented with 10% FCS, 2 mM l-glutamine, and 100 U ml Ϫ1 penicillin/ streptomycin), washed twice with phosphate-buffered saline, and then transferred to DMEM. siRNA oligos were diluted in Opti-MEM (Invitrogen) to a final concentration of 200 nM and mixed with Oligofectamine (Invitrogen). After 4 h of transfection, the medium was replaced with DMEM supplemented with 5% FCS. The cells were returned to growth medium the next day and then harvested 24 -48 h later.
Two-Dimensional (2D) Gel Electrophoresis
Cells were harvested in chilled lysis buffer (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1% Triton X-100, 1 mM DTT, 1 mM activated sodium orthovanadate, 10 mM sodium fluoride, 2 mM sodium pyrophosphate, and 2 mM ␤-glycerophosphate). Lysates were centrifuged at 10,000 ϫ g for 10 min at 4°C. The supernatants were centrifuged at 100,000 ϫ g for 1 h at 4°C. 100 g of the final supernatants were precipitated with 4 volumes of acetone overnight at Ϫ20°C. The precipitates were pelleted at 13,000 ϫ g at 4°C for 10 min, air-dried, and then resuspended in urea/thiourea rehydration solution (7 M urea, 2 M thiourea, 2% 3-[(3-cholamidopropyl)dimethylammonio]propanesulfonate, 0.5% IPG buffer, pH 3-11 NL, 1% DTT, and 0.0005% bromophenol blue). The protein solution was loaded into reswelling trays, and IPG strips (pH 3-10) were applied to the trays. Isoelectric focusing was carried out as follows: 300 V for 4 h, 1000 V for 30 min, 5000 V for 1.5 h, 5000 V for 30 min, and 500 V for 20 h. IPG strips were incubated 10 min each in equilibration buffer (6 M urea, 75 mM Tris-HCl, pH 8.8, 29.3% glycerol, 2% SDS, and 65 mM DTT) and then in equilibration buffer lacking DTT but containing 135 mM iodoacetamide. Strips were then transferred to SDS-polyacrylamide gels for second dimension electrophoresis.
RESULTS
Generation of DGK-deficient Mouse Embryonic Fibroblasts
To investigate potential roles for DGK in Rac1-regulated events, we established immortalized fibroblast cell lines derived from wild-type mice or mice in which the DGK gene was disrupted by homologous recombination (Zhong et al., 2003) . DGK-deficient MEFs did not express detectable levels of the DGK protein (Supplemental Figure S1A ). To determine whether the loss of DGK leads to compensatory up-regulation of other DGK family members, extracts of wt and null MEFs were immunoblotted with an antibody to DGK, the most closely related isoform. No differences in total DGK levels were observed (Supplemental Figure S1B) , suggesting fibroblasts do not compensate for the lack of DGK by modulating the expression of DGK. The levels of several other relevant proteins remained unchanged in the DGK-null cells (Supplemental Figure S1C ).
Decreased Rac1 Activation in the Absence of DGK
To determine whether the absence of DGK affects Rac1 activation, the level of GTP-bound (active) Rac1 was assayed in lysates of wt and null cells by using an effector pull-down assay (Sander et al., 1998) . There was no significant difference in resting Rac1-GTP levels between serum-starved wt and null cell lysates ( Figure 1A ; data not shown). There was a substantial increase in Rac1-GTP levels in wt cell lysates after PDGF stimulation as expected, but only a small increase in null cell lysates ( Figure 1, A and B) . Thus, these data reveal a dramatic decrease in PDGF-dependent Rac1 activation in the absence of DGK. There was no appreciable difference in Cdc42 activity between the wt and null lysates, either with or without bradykinin stimulation ( Figure 1C ). Independent verification of the above-mentioned results was obtained by siRNA knockdown of DGK in HeLa cells. An oligonucleotide targeted to DGK caused a marked reduction in DGK protein levels and a parallel decrease in active Rac, whereas a scrambled version had no discernible effect ( Figure 1D ). To demonstrate that the change in Rac activity is due directly to the loss of DGK, the wt protein was reintroduced into null cells by adenoviral infection (Figure 1E ). Protein expression was verified by immunoblotting cell lysates with an anti-DGK antibody. PDGF-stimu-lated Rac1 activity in lysates of cells expressing wt DGK (AdDGK wt ) was noticeably increased compared with uninfected control cell lysates. In contrast, a kinase-dead mutant (AdDGK kd ) failed to increase active Rac levels. These results strongly suggest the Rac activation defect in null cells is due to the loss of DGK activity.
To determine whether the defect is due to decreased PA production by DGK and hence could be rescued by exogenous PA, wt and null cells were treated with a membranepermeable form of PA, and the lysates were subsequently analyzed for Rac activity ( Figure 1F ). Exogenous PA increased Rac activity in both wt and null cell lysates to a similar extent (ϳ3-4-fold). In control experiments, neither DAG nor LPA caused a detectable increase in Rac activity in DGK-null cells ( Figure 1G ). Collectively, these results suggest DGK-derived PA contributes to the regulation of Rac activity after PDGF stimulation.
Decreased PAK1 phosphorylation in DGK-Null Cells
The PAKs are Ser/Thr protein kinases whose activity is regulated by binding of active Rac or Cdc42. Because Rac1 activity was decreased in DGK-null cells, we investigated whether there was a corresponding decrease in active PAK1. Binding of active Rac or Cdc42 to PAK1 relieves autoinhibition and stimulates autophosphorylation, leading to increased kinase activity (Bokoch, 2003) . Thus, the level of pPAK, as determined by immunoblotting with a phosphospecific antibody, was used to gauge PAK activity. In unstimulated wt cells, two pPAK1 bands were evident ( Figure  2A) ; the upper band most likely represents hyperphosphorylated PAK1 and the lower band, a less phosphorylated version (Sells et al., 2000) . There was a substantial decrease in the levels of both bands in DGK-null cells. When normalized to total PAK1 levels, the intensity of the upper pPAK1 band was only about half that seen in wt cells ( Figure 2B ).
We next assayed pPAK levels in cells stimulated by PDGF, which is known to activate PAK1 (Dharmawardhane et al., 1997) . A previous report noted only a slight increase (28%) in total pPAK1 levels upon PDGF stimulation by measuring the fluorescence intensity of individual, immunolabeled fibroblasts (Sells et al., 2000) . Consistent with this, we found global pPAK levels in PDGF-treated wt cells were not significantly different from unstimulated cells ( Figure  2B ), despite the same concentration of PDGF being able to induce substantial membrane ruffling (data not shown). It is likely that small differences in individual cells do not translate into a biochemically detectable difference among a large population. Nevertheless, as for unstimulated cells, PDGFstimulated null cells had only half as much pPAK1 as wt cells ( Figure 2B ). Extracellular stimuli can activate PAK1 via multiple independent pathways (Bokoch, 2003; Menard and Mattingly, 2003) . Akt, a serine/threonine kinase that is rapidly phosphorylated after growth factor stimulation, phosphorylates PAK1 via a GTPase-independent mechanism (Welch et al., 1998; Tang et al., 2000) . Therefore, we assessed whether the Akt pathway is altered in DGK-null cells by immunoblotting with an anti-pAkt antibody. The loss of DGK had no detectable effect on pAkt levels after PDGF stimulation (Figure 2C ), suggesting signaling upstream of Akt is not impaired in DGK-deficient fibroblasts.
PAK1 Localization
In resting cells, PAK1 is localized to membranous structures within the cytoplasm (Dharmawardhane et al., 1997) . However, active PAK1 preferentially accumulates in dynamic actin-based structures such as focal adhesions and membrane ruffles (Dharmawardhane et al., 1997; Sells et al., 1997 Sells et al., , 2000 , most likely via its association with one or more binding partners (Bokoch et al., 1996; Manser et al., 1998; Bagrodia et al., 1999; Manabe et al., 2002) . To determine whether DGK influences the targeting of active PAK1 to adhesive sites, wt and DGK-null cells were stained for pPAK1 after replating cells for 45 min on fibronectin. As expected, pPAK1 labeling in wt cells was concentrated in focal adhesions (identified by their typical radiating actin bundles) on the cell's circumference ( Figure 2D ). In contrast, pPAK1 was confined to a perinuclear, cytoplasmic compartment in DGK-null cells. At higher magnification, pPAK1 foci in the null cells seem to be organized into circular profiles, suggesting they are associated with cytoplasmic vesicles. The localization of total PAK1 was mainly cytoplasmic and not obviously different in wt and null cells (Supplemental Figure S2A) . We verified that focal adhesions are formed normally in DGK-null cells by using phosphotyrosine immunoreactivity as an indicator of focal adhesion formation (Supplemental Figure S3A) . In wt cells, DGK was not concentrated in the majority of focal adhesions, revealed by staining for phosphorylated FAK (FAK-pY861; Supplemental Figure S3B ). It was, however, codistributed with diffuse FAK-pY861 in areas rich in focal adhesions (Supplemental Figure S3C) . Presumably, these are areas in which focal adhesions are in dynamic flux. Collectively, these data suggest DGK is required for the correct targeting of pPAK1 to focal adhesions but that it does not recruit pPAK to these sites.
In support of an interaction between DGK and pPAK, we found that HA-DGK colocalized with pPAK at the edge of lamellipodia in fibroblasts that were transfected with HA-DGK for 24 h and then replated for 30 min on FN ( Figure  2E ). DGK also specifically coimmunoprecipitated with PAK1 from extracts of wt fibroblasts ( Figure 2F ), suggesting the two proteins form a stable complex in cells.
Decreased RhoGDI Phosphorylation and Rac1 Release in DGK-Null Cells
After PDGF stimulation, PAK1 phosphorylates RhoGDI at two sites to initiate Rac release and activation (Dermardirossian et al., 2004) . Because active PAK1 is decreased in DGKnull cells, we investigated whether there was a parallel reduction in RhoGDI phosphorylation by using 2D gel electrophoresis and immunoblotting. Stimulation of wild-type cells with PDGF induced the appearance of a more acidic RhoGDI spot, consistent with the addition of phosphate groups ( Figure 3A, arrow) . This spot, which seems identical to the spot observed by Dermardirossian et al. (2004) after expression of constitutively active PAK1, was greatly reduced in intensity in DGK-null cells. These data suggest there is a defect in RhoGDI phosphorylation in DGK-null cells in response to PDGF stimulation.
Next, we assessed whether Rac1 release from RhoGDI is attenuated after PDGF stimulation. The amount of Rac1 bound to RhoGDI was assayed by coimmunoprecipitation from lysates of unstimulated and PDGF-stimulated wt and DGK-null cells ( Figure 3B ). Rac1 coprecipitated with RhoGDI from lysates of unstimulated but not stimulated wt cells, suggesting PDGF induces the dissociation of Rac from RhoGDI under these conditions. The amount of Rac1 that coimmunoprecipitated with RhoGDI from unstimulated null cell lysates was comparable to wt; however, PDGF stimulation did not decrease it, suggesting a defect in the release of Rac from RhoGDI in the absence of DGK.
Consistent with the idea that PAK1 acts upstream of RhoGDI and Rac1, treatment of wild type cells with a highly selective, small-molecule PAK1 inhibitor (Deacon et al., 2008) decreased both the steady state and the PDGF-stimulated increase in active Rac levels ( Figure 3C ).
We assessed potential interactions between DGK and RhoGDI by immunoprecipitating the latter from lysates of wt fibroblasts expressing HA-tagged DGK and immunoblotting the bound proteins. HA-DGK was coprecipitated by anti-RhoGDI but not by control IgG (Figure 3D ). In addition, a GST-RhoGDI fusion protein, but not GST alone, captured HA-DGK from fibroblast extracts ( Figure 3E ). Together, these results suggest DGK and RhoGDI form a stable complex in cells.
DGK-Null Fibroblasts Have Fewer Lamellipodia and Membrane Ruffles
Rac1 regulates the formation of lamellipodia and membrane ruffles, structures that are driven by dynamic and spatially regulated changes in the actin cytoskeleton at the leading edge of migrating cells (Ridley et al., 1992) . Two types of ruffles can generally be distinguished in cells stimulated by growth factors: peripheral ruffles, which are associated with active lamellipodia; and dorsal, circular ruffles (Abercrombie et al., 1970) . DGK is concentrated in peripheral ruffles, at the leading edge of lamellipodia Abramovici et al., 2003; Luo et al., 2004a) and in circular ruffles, along with syntrophin and Rac1 (Supplemental Figure S4) . To determine whether the defect in Rac activation affects lamellipodia and/or membrane ruffle production, these structures were quantified in fixed wt and null cells. Lamellipodia were observed in 67 Ϯ 7% of wt fibroblasts grown in serum-containing media but in only in 24 Ϯ 2% of null cells grown under identical conditions ( Figure 4A) . A similar deficiency in lamellipodia formation was noted after PDGF stimulation of serum-starved cells (data not shown). Similarly, PDGF-induced peripheral ruffling was significantly reduced in DGK-null cells ( Figure 4B ). Finally, there was an approximately threefold decrease in the frequency of PDGF-induced circular ruffles in null cells ( Figure 4C ). Circular ruffling in DGK-null cells was rescued by HA-tagged wt DGK but not by a kinase-dead mutant ( Figure 4D ), demonstrating that enzymatic activity is required. Together, these data indicate the formation of lamellipodia and ruffles is impaired by the loss of DGK.
To examine the possibility that ruffle formation is delayed rather than deficient, we compared living wt and null cells using time-lapse digital microscopy. We limited our study to circular ruffles because they are readily imaged using differential interference microscopy and follow a stereotypical time course (Buccione et al., 2004) . After ϳ2-min PDGF stimulation, virtually every wt cell initiated a transient wave of circular ruffling that began at the cell periphery and progressed inwards (Supplemental Video 1). The majority of wt cells had completed ruffling 10 min after the onset of stimulation. In contrast, circular ruffling was severely impaired in DGK-null cells (Supplemental Video 2). Only a few null cells formed ruffles and in those that did, the ruffles were delayed by 1-2 min and were usually smaller and much less conspicuous. No additional circular ruffling was initiated for the duration of the recording (15 min). Thus, video imaging reveals a profound defect in circular ruffling in DGK-null cells. 
Impaired Lamellipodia Formation in DGK-Null Cells
Given the failure of DGK-null cells to assemble PAK1 at focal adhesions, we evaluated the extent of integrin-mediated cell spreading and the morphology of the spreading cells by immunofluorescence microscopy at various times after replating on fibronectin. Wild-type cells stained for actin were generally cuboid and had numerous membrane ruffles ( Figure 5A ). After 60 min, they had fewer ruffles and were generally well spread. In contrast, null cells were stellate and had numerous large filopodia and substantially fewer membrane ruffles. However, the extent of spreading at 60 min was not significantly different. Quantitative analysis revealed a substantial reduction in membrane ruffling in the null cells 15 and 30 min after replating and a proportional increase in filopodia. Thus, DGK-null cells seem to have a defect in lamellipodial formation but normal filopodial extension.
Migration Is Impaired in DGK-deficient Fibroblasts
Wounding of a confluent cell monolayer induces lamellipodia formation and membrane ruffling at the leading edge; this requires Rac1 and Cdc42 activity (Nobes and Hall, 1999) . We therefore assessed the ability of wt and DGK-null MEFs to undergo coordinated cell migration in a wound closure assay (Nobes and Hall, 1999; Fenteany et al., 2000) . DGK-null cells exhibited a marked reduction in wound closure compared with wt cells when assayed 2 h after wounding ( Figure 6, A and B) . By 4 h after wounding, however, both wt and null MEFs had closed the wound, indicating that migration is not completely blocked in the null cells (data not shown). These data suggest DGK-null MEFs migrate less than their wt counterparts.
To determine whether the loss of DGK was the primary cause of the reduced migration, the wt protein was reintroduced into null MEFs. We verified that exogenously expressed DGK was properly localized in the null fibroblasts. In wt fibroblasts, endogenous DGK colocalized with Rac1 in lamellipodia along the edge of cells facing the wound ( Figure 6C ), consistent with previous reports (Abramovici et al., 2003; Luo et al., 2004a) . Similarly, HA-DGK was concentrated at the leading edge of null MEFs migrating into the wound, where it colocalized with actin ( Figure 6C ). These data suggest exogenous DGK is correctly targeted to the front of migrating cells. Consistent with this finding, HA-DGK restored the migration of null MEFs to near wt levels, whereas expression of GFP in the null MEFs did not significantly increase wound closure (Figure 6, D and E) . Collectively, these data suggest the migration defect of the null MEFs is directly attributable to the loss of DGK and that proteins required for normal DGK localization are largely unaltered.
Three-dimensional migration was assessed using modified Boyden chamber assays. The number of DGK-null MEFs that randomly migrated through a porous membrane (haptotaxis) was not significantly different from wt MEFs after 4 h ( Figure 6F ). However, in response to a PDGF gradient, significantly fewer null cells migrated across the membrane (chemotaxis), suggesting directional migration is impaired.
DISCUSSION
The interaction of Rho family proteins with RhoGDI is a major point of regulation of GTPase activity. Because they share a common inhibitor, different mechanisms should exist to specifically dissociate Rho GTPases from RhoGDI. However, the signaling mechanisms responsible are poorly understood (Dermardirossian et al., 2004; Dovas and Couchman, 2005) . Our results suggest DGK is part of a signaling complex that functions as a Rac1-selective RhoGDI dissociation factor.
The finding that the basal Rac1-GTP level was unaffected in DGK-null cells but that the PDGF-stimulated level was substantially decreased compared with wt cells indicates a defect in Rac1 activation. Consistent with such a defect, the phenotype of the cells is remarkably similar to that of Rac1-null MEFs including; altered morphology, defects in lamellipodia formation and membrane ruffling, and a marked reduction in PAK phosphorylation (Nobes and Hall, 1999 ; Guo et al., 2006; Vidali et al., 2006) . In contrast, Cdc42 activity did not seem to be impaired in the absence of DGK. Supporting this conclusion, DGK-null cells replated on FN contained numerous filopodia, which are regulated by integrin-induced activation of Cdc42 (Price et al., 1998) .
The finding that Rac and RhoGDI associate with enzymes regulating phosphoinositide metabolism, including DGK and phosphoinositide kinase 5, lead to the suggestion of a lipid kinase signaling complex that regulates Rac activation (Tolias et al., 1998 (Tolias et al., , 2000 . Our data showing DGK binds directly to Rac1 (Yakubchyk et al., 2005) and associates in a complex with RhoGDI and PAK1 supports the idea that Rac1 resides in a regulated signaling complex whose function is to control the selective activation of Rac1 and the regulation of actin cytoskeletal dynamics. Moreover, because DGK also associates with phospholipase C (PLC) ␥1 (Luo et al., 2004b) , which hydrolyzes phosphatidylinositol 4,5-bisphosphate to yield DAG and inositol triphosphate, it seems to occupy a central position in an inositol lipid signaling pathway leading to Rac activation.
Phosphatidic Acid and Rac Activity
The role phosphoinositides play in Rac activity is complex; they act both upstream and downstream of Rac to drive actin reorganization in response to extracellular signals (Burridge and Wennerberg, 2004) . The available evidence suggests PA and other anionic phospholipids lie upstream of Rac activation. PA dissociates Rac1-RhoGDI complexes (Bourmeyster et al., 1992; Chuang et al., 1993a; Mesmin et al., 2004; Tolias et al., 1998; Ugolev et al., 2006) and activates PAK1 , which has been shown to phosphorylate RhoGDI and initiate Rac release (Dermardirossian et al., 2004) . Our results provide evidence that DGK-derived PA activates PAK1, initiating the release of Rac1 from RhoGDI. This conclusion is supported by our findings that in DGK-null cells both active Rac1 and pPAK1 were substantially reduced, RhoGDI phosphorylation was decreased, and Rac release from RhoGDI was impaired. That Rac activation in the null cells was rescued by wt DGK, but not by a kinase inactive mutant, suggests enzymatic conversion of DAG to PA is required. Finally, addition of exogenous PA, but not DAG or LPA, increased Rac1 activity in the DGKnull MEFs.
PA may play multiple roles in Rac activation. In addition to stimulating PAK activity, negatively charged PA may function as a lipid anchor by binding positively charged residues at the C terminus of Rac1. Indeed, the polybasic region is required in addition to the C-terminal isoprenyl group of Rac1 for membrane targeting (Joseph et al., 1994; Kreck et al., 1996; Ueyama et al., 2005) . The interaction of the polybasic region with DGK-derived PA could facilitate shuttling of the C-terminal isoprenyl group from the hydrophobic pocket in RhoGDI to the inner leaflet of the plasma membrane.
Regulation of PAK Activity and Localization
The absence of DGK affected both the level and targeting of pPAK, without affecting total PAK1. However, pPAK levels were not reduced to zero, suggesting other phosphorylation mechanisms remain active in DGK-null cells. Both PDK1 and Akt phosphorylate PAK1 in response to PDGF stimulation (Franke et al., 1995; King et al., 2000; Tang et al., 2000) , and Cdc42 can activate PAK upon adhesion to FN (Price et al., 1998) . Because Akt and Cdc42 activities were largely unaffected in the DGK-null MEFs, they could account for the residual PAK phosphorylation.
In addition to phosphorylation, subcellular localization probably plays a key role in the regulation of PAK1 activity. In resting cells PAK1 localizes to cytosolic vesicles, but in stimulated cells, the active form accumulates in membrane ruffles and focal adhesions (Dharmawardhane et al., 1997; Manser et al., 1997; Sells et al., 2000) . Targeting of active PAK to these structures influences cytoskeletal dynamics through phosphorylation of a variety of downstream effectors (Edwards et al., 1999; Sanders et al., 1999; Slack-Davis et al., 2003) . The spatial regulation of PAK1 involves a GIT1-PIXpaxillin complex that promotes autophosphorylation and recruits the kinase from the cytosol to focal adhesions and the leading edge (Zhao et al., 2000; Manabe et al., 2002; Brown et al., 2002; Loo et al., 2004) . Our data suggest DGK is also necessary for the translocation of pPAK1 from the cytosol to focal adhesions. In contrast, targeting of pPAK1 to membrane ruffles at the leading edge of the null cells was seemingly unaffected, so DGK does not seem to be required for this translocation event.
Integrin-mediated Cell Spreading
Integrins transduce signals from the extracellular matrix (ECM) to the actin cytoskeleton through pathways regulated by Rho GTPases (Clark et al., 1998) . Focal adhesions serve as convergence points for rapid integration of growth factorand integrin-mediated signaling responses (Plopper et al., 1995) . Consistent with this idea, integrin engagement stimulates rapid assembly of structural and signaling components into focal adhesions, including both synthetic and degradative enzymes of the inositol lipid signaling cascade. Moreover, adhesion of fibroblasts to the ECM is required for PDGF-dependent hydrolysis of phosphatidylinositol bisphosphate (PIP 2 ) into DAG and inositol-1,4,5-trisphosphate (McNamee et al., 1993) . Consistent with a defect in integrin-mediated signaling events, DGK-null MEFs exhibited reduced spreading after plating on FN. However, after longer periods, the surface area of DGK-null cells was not significantly different from wt cells. Because both lamellipodia and membrane ruffling were substantially decreased in the null cells, the residual spreading may be mediated by blunt filopodia and/or pseudopodia, which have been suggested to mediate spreading of Rac1-null cells (Vidali et al., 2006) .
Integrins contribute to spatial regulation of Rac function by dissociating it from RhoGDI and enhancing its interaction with effectors at cell edges (Del Pozo et al., 2002) . They also stimulate Rac membrane translocation by modulating the local lipid environment and preventing internalization of cholesterol-rich membrane domains (Del Pozo et al., 2004) . Integrin activation stimulates PIP 2 hydrolysis to DAG by activating PLC␥ (Auer and Jacobson, 1995) ; the latter reaction is enhanced by PDGF stimulation (McNamee et al., 1993) . In this regard, DGK is positioned to integrate signals from the two inputs and to generate an output (PA) that activates PAK1 and dissociates Rac1 from RhoGDI.
Proposed Mechanism of Rac Release from RhoGDI
On the basis of these and previous findings (Tolias et al., 1998; Dermardirossian et al., 2004) , we propose DGK exists in a multiprotein signaling complex with syntrophin, Rac1, PAK1 and RhoGDI and that DGK-derived PA activates PAK1, which subsequently phosphorylates RhoGDI to trigger Rac1 release (Figure 7) . Thus, DGK occupies a key position in the signaling pathway from PIP 2 breakdown to Rac activation. Together, these results establish a mechanism whereby changes in lipid second messengers modulate the amount of active Rac and thus contribute to the regulation of the actin cytoskeleton. Model for the release of Rac1 from RhoGDI. Left, DGK-catalyzed conversion of DAG to PA (curved arrow) activates PAK1 (dashed arrow) which undergoes autophosphorylation (P). The C-terminal lipid moiety of Rac1-GDP is sequestered in a hydrophobic pocket of RhoGDI. Middle, PAK1-mediated phosphorylation of RhoGDI at two sites releases the lipid group. DGK binding to Rac1 may facilitate insertion of the lipid group into the plasma membrane. Right, membrane translocation allows Rac to interact with a GEF and to become activated. Syn, syntrophin.
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